Grossman William bought ENGN
June 16, 2026 · Form 4 insider transaction
Grossman William bought 200,000 shares of enGene Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
200,000
Price
$0.00
Total value
N/A
InsiderGrossman William
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 16, 2026
Filing dateJune 17, 2026
Shares owned after200,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option vests monthly in substantially equal amounts on the 12th day of each month for 12 consecutive months, subject to the reporting person's continued service as Interim Chief Medical Officer at the time of each vesting. These options were granted to the reporting person in connection with his appointment as the Interim Chief Medical Officer of the Company.